News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
Study supports expansion of first human trial to include those with cervical spinal cord damage
12-Nov-2009 - The first human embryonic stem cell treatment approved by the FDA for human testing has been shown to restore limb function in rats with neck spinal cord injuries – a finding that could expand the clinical trial to include people with cervical damage. In January, the U.S. Food & Drug ...
04-Sep-2007 - In May 2004 the US biotech company Geron filed an opposition against Pharmexa's issued European patent (EP1093381) covering the telomerase vaccine GV1001. In 2005, the Opposition Division of the European Patent Office refused to grant Geron's request for invalidation of the issued patent, but ...
23-Apr-2007 - Geron Corporation announced that it has developed standardized hepatocytes from human embryonic stem cells (hESCs) that can model human hepatic drug metabolism. Published in Cloning and Stem Cells (Vol. 9, No. 1, 51-62), a paper written by Geron's scientific collaborators at the Roslin Institute ...
12-Apr-2007 - GTC Biotherapeutics, Inc. announced that it has been granted a non-exclusive worldwide license from Start Licensing, Inc., a joint venture between Geron Corporation and Exeter Life Sciences, Inc., for the patents and patent applications developed by the Roslin Institute to apply nuclear transfer ...
19-Jan-2007 - Geron Corporation reported that studies show GRNOPC1, the company's human embryonic stem cell (hESC)-based oligodendroglial progenitor therapeutic, produces multiple nerve growth factors, proteins that stimulate the survival and regeneration of neurons damaged during spinal cord injury. The ...
14-Nov-2006 - Geron Corporation announced the first clinical trial data for its telomerase inhibitor cancer drug, GRN163L. Presented by Laurence Elias, M.D., Geron's vice president, oncology clinical development, the data demonstrate the safety, tolerability and predicted pharmacokinetics in low-dose cohorts ...
07-Nov-2006 - Geron Corporation and Immunomic Therapeutics Inc. (ITI) announced a patent license agreement under which Geron will receive exclusive rights to the LAMP antigen targeting sequence for use in cancer vaccines. Geron's therapeutic cancer vaccine, GRNVAC1, triggers an immune response against the ...
18-Oct-2006 - Geron Corporation announced the appointment of Alan B. Colowick, M.D., M.P.H., as president, oncology. In this newly created position, Dr. Colowick, 44, will manage the operational and strategic activities of the company's oncology programs. He will report to Dr. Thomas Okarma, Geron's president ...
09-Aug-2006 - Geron Corporation and the University of Edinburgh have entered into a collaboration to conduct preclinical safety and efficacy studies with three cell types derived from human embryonic stem cells (hESCs). The cell types are hepatocytes for the treatment of liver failure and osteoblasts and ...
04-Jul-2006 - Invitrogen Corporation and Geron Corporation announced that Invitrogen has licensed Geron intellectual property related to the growth of human embryonic stem cells (hESCs). The agreement provides Invitrogen with a non-exclusive license under Geron's patents to develop, manufacture and sell ...
© 1997-2024 LUMITOS AG, All rights reserved